Fabrazyme Injection, Powder, Lyophilized, For Solution
Product Images NDC 58468-0041

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fabrazyme (NDC 58468-0041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fabrazyme 01

Fabrazyme agalsidase beta 5 mg injection, powder, lyophilized, for intravenous infusion, in a single-dose vial. The folded carton label shows storage instructions to refrigerate at 2-8°C and warnings not to freeze or shake. The labeler is Genzyme Corporation, Cambridge, MA. The label includes a barcode and placeholder for serialization information.*

FDA Label Image

Fabrazyme 02

The image shows the carton label for Fabrazyme 35 mg injection, lyophilized powder for solution. It specifies the drug is for intravenous infusion only and contains one single-dose vial. The label includes storage instructions to refrigerate at 2-8°C (36-46°F), warnings not to freeze or shake, and manufacturer details for Sanofi Genzyme Corporation. The label also lists the vial's contents and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.